68 related articles for article (PubMed ID: 10764312)
21. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group.
Miravitlles M; Guerrero T; Mayordomo C; Sánchez-Agudo L; Nicolau F; Segú JL
Respiration; 2000; 67(5):495-501. PubMed ID: 11070451
[TBL] [Abstract][Full Text] [Related]
22. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
Tashkin DP
Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
[TBL] [Abstract][Full Text] [Related]
23. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
Kerstjens HA; Brand PL; Hughes MD; Robinson NJ; Postma DS; Sluiter HJ; Bleecker ER; Dekhuijzen PN; de Jong PM; Mengelers HJ
N Engl J Med; 1992 Nov; 327(20):1413-9. PubMed ID: 1357553
[TBL] [Abstract][Full Text] [Related]
24. "Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial.
Davies L; Wilkinson M; Bonner S; Calverley PM; Angus RM
BMJ; 2000 Nov; 321(7271):1265-8. PubMed ID: 11082090
[TBL] [Abstract][Full Text] [Related]
25. Role of corticosteroids in acute exacerbations of chronic obstructive pulmonary disease.
Niewoehner DE
Curr Opin Pulm Med; 2001 Mar; 7(2):75-8. PubMed ID: 11224727
[TBL] [Abstract][Full Text] [Related]
26. Systemic glucocorticoids in severe exacerbations of COPD.
Sayiner A; Aytemur ZA; Cirit M; Unsal I
Chest; 2001 Mar; 119(3):726-30. PubMed ID: 11243949
[TBL] [Abstract][Full Text] [Related]
27. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease.
Rodrigues J; Niederman MS; Fein AM; Pai PB
Am J Med; 1992 Jul; 93(1):29-34. PubMed ID: 1626569
[TBL] [Abstract][Full Text] [Related]
28. Diaphragm injury in individuals with airflow obstruction.
Macgowan NA; Evans KG; Road JD; Reid WD
Am J Respir Crit Care Med; 2001 Jun; 163(7):1654-9. PubMed ID: 11401890
[TBL] [Abstract][Full Text] [Related]
29. How to predict exacerbations and hospital admissions in stable COPD outpatients.
Pistelli F; Viegi G
Respiration; 2000; 67(5):491-2. PubMed ID: 11185489
[No Abstract] [Full Text] [Related]
30. FEV(6) as screening tool in diagnosis of obstructive airway disease.
Aggarwal S
Lung India; 2010 Oct; 27(4):262. PubMed ID: 21139733
[No Abstract] [Full Text] [Related]
31. Magnetic structure of ordered FeAl and FeV.
Moruzzi VL; Marcus PM
Phys Rev B Condens Matter; 1993 Apr; 47(13):7878-7884. PubMed ID: 10004793
[No Abstract] [Full Text] [Related]
32. Review of the prevalence, pathogenesis and management of OSA-COPD overlap.
Brennan M; McDonnell MJ; Walsh SM; Gargoum F; Rutherford R
Sleep Breath; 2022 Dec; 26(4):1551-1560. PubMed ID: 35034250
[TBL] [Abstract][Full Text] [Related]
33. Harnessing Digital Health to Objectively Assess Functional Performance in Veterans with Chronic Obstructive Pulmonary Disease.
Zhou H; Park C; Poursina O; Zahiri M; Nguyen H; Torres Ruiz I; Nguyen CK; Bryant MS; Sharafkhaneh A; Bandi VD; Najafi B
Gerontology; 2022; 68(7):829-839. PubMed ID: 34844245
[TBL] [Abstract][Full Text] [Related]
34. Exacerbations of chronic obstructive pulmonary disease and chronic mucus hypersecretion.
Tesfaigzi Y; Meek P; Lareau S
Clin Appl Immunol Rev; 2006; 6(1):21-36. PubMed ID: 32288656
[TBL] [Abstract][Full Text] [Related]
35. Assessing upper-extremity motion: An innovative method to quantify functional capacity in patients with chronic obstructive pulmonary disease.
Toosizadeh N; Berry C; Bime C; Najafi B; Kraft M; Mohler J
PLoS One; 2017; 12(2):e0172766. PubMed ID: 28235045
[TBL] [Abstract][Full Text] [Related]
36. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
[TBL] [Abstract][Full Text] [Related]
38. Three-month treatment response and exacerbation in chronic obstructive pulmonary disease.
Lee JS; Rhee CK; Yoo KH; Lee JH; Yoon HI; Kim TH; Kim WJ; Lee J; Lim SY; Park TS; Lee JS; Lee SW; Lee SD; Oh YM
J Korean Med Sci; 2015 Jan; 30(1):54-9. PubMed ID: 25552883
[TBL] [Abstract][Full Text] [Related]
39. Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?
Miles MC; Donohue JF; Ohar JA
Drugs; 2012 Feb; 72(3):301-8. PubMed ID: 22316346
[TBL] [Abstract][Full Text] [Related]
40. Chronic obstructive pulmonary disease phenotypes: the future of COPD.
Han MK; Agusti A; Calverley PM; Celli BR; Criner G; Curtis JL; Fabbri LM; Goldin JG; Jones PW; Macnee W; Make BJ; Rabe KF; Rennard SI; Sciurba FC; Silverman EK; Vestbo J; Washko GR; Wouters EF; Martinez FJ
Am J Respir Crit Care Med; 2010 Sep; 182(5):598-604. PubMed ID: 20522794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
